It is noteworthy that while multiple drug concentrations may be designed in other studies, for our study, minimizing the drug dose while achieving its effect was considered for safety reasons, given that PE is a pregnancy-related disease, and medication use during pregnancy is restricted
As of May 2025, New York regulations (10 NYCRR 80.63) require that providers conduct at least one in-person medical evaluation before prescribing any controlled substance to a patient (www.cchpca.org)
Retatrutide + NAD+: Exploring the relationship between glucose metabolism and cellular redox states
10.1517/14728220802517901 Expert Opin Biol Ther
providing 240 IU protected superoxide dismutase)Other ingredients: Capsule shell (hydroxypropyl methylcellulose), Microcrystalline cellulose, Magnesium stearate, Silica
doi:10.1038/s41598-020-80171-x